Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Behjatolah Karbassi

Concepts (272)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antigens, Tumor-Associated, Carbohydrate
15
2023
24
3.770
Why?
Cancer Vaccines
13
2022
80
2.580
Why?
Peptides
17
2022
221
2.520
Why?
Carbohydrates
14
2009
38
2.340
Why?
Molecular Mimicry
13
2007
38
1.980
Why?
Breast Neoplasms
12
2024
1201
1.680
Why?
Neoplasms
9
2022
1251
1.460
Why?
Immunotherapy
6
2022
235
1.090
Why?
Epitopes, T-Lymphocyte
6
2009
25
0.880
Why?
HIV Envelope Protein gp120
4
2009
9
0.830
Why?
Lung Neoplasms
4
2014
601
0.820
Why?
HIV-1
4
2009
54
0.800
Why?
Antibodies, Neoplasm
2
2017
28
0.800
Why?
Mice, Inbred BALB C
16
2011
296
0.780
Why?
Antigens
4
2003
41
0.760
Why?
Animals
31
2023
13124
0.660
Why?
Epithelial-Mesenchymal Transition
2
2020
51
0.640
Why?
Clinical Trials, Phase I as Topic
2
2017
25
0.620
Why?
Gene Expression Regulation, Neoplastic
5
2020
833
0.610
Why?
Vaccines, DNA
6
2006
12
0.600
Why?
Immunologic Surveillance
2
2009
11
0.600
Why?
HIV Antigens
3
2006
9
0.580
Why?
Epitopes
3
2009
59
0.560
Why?
Cell Transformation, Neoplastic
1
2018
181
0.560
Why?
Antineoplastic Agents
3
2017
1172
0.530
Why?
Immunity, Innate
3
2018
105
0.530
Why?
Molecular Targeted Therapy
1
2017
123
0.510
Why?
Neoplasm Proteins
1
2018
320
0.510
Why?
Mice
20
2011
5687
0.500
Why?
Cell Hypoxia
1
2015
82
0.470
Why?
Biomimetic Materials
1
2014
10
0.470
Why?
Epigenesis, Genetic
1
2018
372
0.470
Why?
Estrogen Receptor alpha
1
2015
88
0.470
Why?
Vaccines
4
2002
50
0.440
Why?
T-Lymphocytes
7
2010
325
0.440
Why?
Cross Reactions
8
2006
39
0.430
Why?
Oligosaccharides
4
2007
34
0.430
Why?
Amino Acid Sequence
9
2006
574
0.430
Why?
Molecular Sequence Data
9
2006
778
0.420
Why?
Sarcoma, Experimental
2
2004
13
0.420
Why?
Humans
35
2024
50503
0.420
Why?
Antigens, Neoplasm
5
2007
148
0.410
Why?
Polysaccharides
2
2011
51
0.410
Why?
AIDS Vaccines
3
2009
8
0.400
Why?
Isoflavones
1
2023
89
0.390
Why?
Plant Lectins
2
2010
8
0.390
Why?
Sulfotransferases
3
2020
39
0.380
Why?
Chondroitin Sulfates
2
2011
13
0.370
Why?
Soybean Proteins
1
2023
161
0.370
Why?
P-Selectin
2
2011
32
0.370
Why?
CD8-Positive T-Lymphocytes
3
2007
125
0.360
Why?
Autoantigens
1
2011
48
0.350
Why?
Fructose
1
2010
22
0.350
Why?
Carbon
1
2010
55
0.350
Why?
Adaptive Immunity
1
2010
32
0.340
Why?
CD4-Positive T-Lymphocytes
3
2006
158
0.330
Why?
Vaccines, Subunit
3
2006
15
0.330
Why?
Obesity
2
2023
1121
0.330
Why?
Drug Delivery Systems
1
2010
143
0.300
Why?
Carcinoma, Ductal
1
2008
7
0.300
Why?
Proteoglycans
3
2023
83
0.290
Why?
Mammary Neoplasms, Experimental
2
2005
121
0.290
Why?
Interferon-gamma
4
2018
177
0.290
Why?
Carcinoma in Situ
1
2008
73
0.290
Why?
Cell Line, Tumor
6
2011
1398
0.280
Why?
Dendritic Cells
3
2005
135
0.270
Why?
T-Lymphocytes, Cytotoxic
5
2009
63
0.270
Why?
Female
18
2024
27081
0.270
Why?
Concanavalin A
2
2005
11
0.250
Why?
HIV Infections
1
2009
352
0.250
Why?
Sarcoma
1
2006
65
0.250
Why?
Mammary Neoplasms, Animal
1
2005
35
0.240
Why?
Ligands
5
2011
203
0.240
Why?
MCF-7 Cells
4
2020
62
0.240
Why?
Neoplasm Metastasis
5
2015
232
0.230
Why?
Magnetic Resonance Spectroscopy
1
2005
244
0.230
Why?
Acetylglucosamine
1
2004
6
0.230
Why?
Histocompatibility Antigens Class I
1
2004
46
0.220
Why?
Combined Modality Therapy
2
2017
641
0.220
Why?
Melanoma
1
2007
280
0.220
Why?
Immunoglobulin G
2
2003
190
0.210
Why?
Immunotherapy, Active
1
2003
4
0.210
Why?
Peptide Fragments
1
2004
209
0.210
Why?
Peptide Library
4
2005
16
0.210
Why?
Autoantibodies
2
2018
117
0.200
Why?
Glycosylation
3
2010
102
0.200
Why?
Cell Proliferation
4
2020
985
0.200
Why?
Antigens, Viral
1
2002
42
0.200
Why?
Antibodies, Monoclonal
5
2023
462
0.190
Why?
Apoptosis
2
2020
1097
0.190
Why?
Biochemistry
1
2001
5
0.190
Why?
Enzyme-Linked Immunosorbent Assay
3
2010
234
0.190
Why?
Liver Neoplasms
1
2005
326
0.190
Why?
Cell Adhesion
3
2006
157
0.180
Why?
CHO Cells
3
2006
118
0.170
Why?
Carbamates
1
2020
16
0.170
Why?
Cricetinae
3
2006
188
0.170
Why?
Adjuvants, Immunologic
2
2014
51
0.170
Why?
Colchicine
1
2020
23
0.170
Why?
Antineoplastic Agents, Phytogenic
1
2020
66
0.170
Why?
Carcinoma, Ductal, Breast
1
2020
91
0.160
Why?
Neoplastic Stem Cells
1
2020
98
0.160
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2020
81
0.160
Why?
Tumor Microenvironment
2
2024
222
0.150
Why?
Anthroposophy
1
2018
1
0.150
Why?
Tumor Cells, Cultured
3
2015
457
0.150
Why?
Antibody Formation
3
2003
50
0.150
Why?
Cell Division
3
2006
291
0.150
Why?
Gene-Environment Interaction
1
2018
36
0.150
Why?
Immunization
3
2004
62
0.150
Why?
Immune Tolerance
2
2009
84
0.150
Why?
Chondroitin Sulfate Proteoglycans
2
2023
18
0.150
Why?
Plant Extracts
1
2020
174
0.150
Why?
Flow Cytometry
3
2006
474
0.140
Why?
Cell Movement
4
2020
247
0.140
Why?
Spleen
3
2004
169
0.140
Why?
Homeostasis
1
2018
204
0.140
Why?
Clinical Trials, Phase II as Topic
1
2017
45
0.140
Why?
Forecasting
1
2017
147
0.130
Why?
HIV Antibodies
2
2006
10
0.130
Why?
Models, Immunological
2
2007
7
0.130
Why?
Membrane Proteins
2
2023
332
0.120
Why?
Lectins
2
2006
14
0.120
Why?
Interleukin-12
2
2006
29
0.120
Why?
Phenotype
2
2010
739
0.120
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2015
57
0.120
Why?
Coculture Techniques
1
2015
142
0.120
Why?
Drug Therapy
1
2014
47
0.120
Why?
Transforming Growth Factor beta
1
2015
136
0.110
Why?
Antibodies
1
2014
153
0.110
Why?
Adipocytes
1
2015
126
0.110
Why?
Vaccines, Conjugate
2
2005
7
0.110
Why?
Nuclear Proteins
1
2015
238
0.110
Why?
Cell Separation
2
2005
92
0.110
Why?
Rats, Zucker
1
2023
68
0.100
Why?
Scavenger Receptors, Class E
1
2015
203
0.100
Why?
Positron-Emission Tomography
1
2014
292
0.100
Why?
Cytotoxicity, Immunologic
2
2005
55
0.100
Why?
Mutation
1
2018
1280
0.100
Why?
Protein Binding
2
2005
654
0.100
Why?
Immunity, Cellular
2
2003
63
0.100
Why?
Mice, Nude
2
2004
248
0.100
Why?
Lymphocyte Activation
3
2001
164
0.100
Why?
C-Reactive Protein
1
2023
144
0.100
Why?
Kinetics
2
2005
623
0.100
Why?
Injections, Intramuscular
2
2003
48
0.100
Why?
Interleukin-6
1
2023
261
0.090
Why?
Binding Sites
2
2003
362
0.090
Why?
Prognosis
3
2020
1978
0.090
Why?
Tumor Necrosis Factor-alpha
1
2023
393
0.090
Why?
Microscopy, Phase-Contrast
1
2010
12
0.090
Why?
Body Weight
1
2023
517
0.090
Why?
Lung
1
2014
504
0.090
Why?
DNA Methylation
1
2015
550
0.090
Why?
B-Lymphocytes
2
2002
171
0.090
Why?
Transfection
3
2007
356
0.090
Why?
Antigens, CD
2
2003
222
0.090
Why?
Substrate Specificity
1
2010
192
0.090
Why?
Membrane Glycoproteins
2
2003
245
0.090
Why?
Actins
1
2010
114
0.090
Why?
Dose-Response Relationship, Drug
2
2005
1372
0.080
Why?
Antibodies, Catalytic
1
2009
1
0.080
Why?
Receptors, CCR5
1
2009
6
0.080
Why?
Neoplasm Invasiveness
1
2010
269
0.080
Why?
Cells, Cultured
2
2003
1571
0.080
Why?
Time Factors
2
2005
2935
0.080
Why?
Killer Cells, Natural
1
2009
106
0.080
Why?
Male
3
2023
25907
0.070
Why?
Fucosyltransferases
1
2007
5
0.070
Why?
Glycosaminoglycans
1
2007
19
0.070
Why?
Molecular Biology
1
2007
23
0.070
Why?
Binding Sites, Antibody
1
2006
15
0.070
Why?
Amino Acid Motifs
1
2006
55
0.070
Why?
Rats
1
2023
3292
0.070
Why?
Cricetulus
1
2006
97
0.070
Why?
Heparin
1
2007
91
0.070
Why?
Antineoplastic Agents, Alkylating
1
2006
73
0.060
Why?
Cell Membrane
1
2007
246
0.060
Why?
E-Selectin
1
2005
14
0.060
Why?
Xenograft Model Antitumor Assays
1
2006
212
0.060
Why?
Cyclophosphamide
1
2006
168
0.060
Why?
Hydrocarbons
1
2005
5
0.060
Why?
Densitometry
1
2005
11
0.060
Why?
Mannose
1
2005
16
0.060
Why?
Wheat Germ Agglutinins
1
2005
3
0.060
Why?
Methane
1
2005
9
0.060
Why?
Surface Plasmon Resonance
1
2005
21
0.060
Why?
Phosphorylcholine
1
2005
20
0.060
Why?
Bone Marrow Cells
1
2006
196
0.060
Why?
Biosensing Techniques
1
2005
25
0.060
Why?
Growth Inhibitors
1
2005
27
0.060
Why?
Calcium
1
2007
398
0.060
Why?
Genetic Variation
1
2006
207
0.060
Why?
Glycolysis
1
2005
69
0.060
Why?
Immunoglobulins
1
2005
81
0.060
Why?
Oligonucleotide Array Sequence Analysis
1
2006
405
0.060
Why?
Antigen Presentation
1
2004
25
0.060
Why?
Endothelial Cells
1
2006
258
0.060
Why?
Treatment Outcome
1
2014
5283
0.060
Why?
Bone Neoplasms
1
2006
179
0.060
Why?
Cytosol
1
2004
78
0.060
Why?
Immunoglobulin Constant Regions
1
2003
3
0.060
Why?
Plasmids
2
2003
164
0.060
Why?
Recombinant Proteins
1
2005
476
0.060
Why?
Middle Aged
2
2020
12611
0.050
Why?
Histocompatibility Antigens Class II
1
2003
37
0.050
Why?
Antibodies, Viral
1
2003
94
0.050
Why?
Bacterial Capsules
1
2003
18
0.050
Why?
Immunoglobulin M
1
2003
58
0.050
Why?
DNA, Neoplasm
1
2003
143
0.050
Why?
Th1 Cells
1
2003
53
0.050
Why?
Carbohydrate Metabolism
1
2002
26
0.050
Why?
Antibodies, Anti-Idiotypic
1
2002
25
0.050
Why?
Models, Chemical
1
2002
64
0.050
Why?
L-Selectin
1
2001
7
0.050
Why?
Calorimetry
1
2001
6
0.050
Why?
Carbohydrate Sequence
1
2001
11
0.050
Why?
Epitope Mapping
1
2001
6
0.050
Why?
Thermodynamics
1
2001
33
0.050
Why?
Binding, Competitive
1
2001
94
0.050
Why?
Mice, Inbred CBA
1
2001
35
0.050
Why?
Gene Expression Profiling
1
2006
1025
0.050
Why?
Protein Structure, Secondary
1
2001
71
0.050
Why?
Sequence Homology, Amino Acid
1
2001
144
0.050
Why?
Protein Conformation
1
2001
162
0.040
Why?
Antibody-Dependent Cell Cytotoxicity
1
2000
12
0.040
Why?
Injections, Intraperitoneal
1
2000
59
0.040
Why?
Colchicum
1
2020
3
0.040
Why?
Inhibitory Concentration 50
1
2020
69
0.040
Why?
Models, Molecular
1
2001
334
0.040
Why?
Drug Screening Assays, Antitumor
1
2020
131
0.040
Why?
Wnt Signaling Pathway
1
2020
86
0.040
Why?
Child, Preschool
1
2008
3942
0.040
Why?
H-2 Antigens
1
1999
3
0.040
Why?
Receptors, Estrogen
1
2020
132
0.040
Why?
Transformation, Genetic
1
1998
18
0.040
Why?
Glycoside Hydrolases
1
1998
17
0.040
Why?
Clostridium
1
1998
17
0.040
Why?
Cell Survival
1
2020
589
0.040
Why?
Plants
1
1998
26
0.040
Why?
Genes, Reporter
1
1998
88
0.040
Why?
Models, Biological
1
2001
716
0.040
Why?
Survival Rate
1
2020
909
0.040
Why?
Adolescent
1
2008
6443
0.030
Why?
Retrospective Studies
1
2008
6263
0.030
Why?
Child
1
2008
6906
0.030
Why?
CpG Islands
1
2015
108
0.030
Why?
Disease Progression
1
2015
829
0.020
Why?
RNA Interference
1
2011
178
0.020
Why?
RNA, Small Interfering
1
2011
208
0.020
Why?
Lymphocyte Subsets
1
2003
14
0.010
Why?
Simian virus 40
1
2003
14
0.010
Why?
Immunoglobulin Variable Region
1
2003
15
0.010
Why?
Mutagenesis, Site-Directed
1
2003
95
0.010
Why?
Sequence Deletion
1
2003
67
0.010
Why?
Protein Structure, Tertiary
1
2003
245
0.010
Why?
Recombinant Fusion Proteins
1
2003
179
0.010
Why?
Down-Regulation
1
2003
340
0.010
Why?
Up-Regulation
1
2003
446
0.010
Why?
HIV Envelope Protein gp160
1
1999
2
0.010
Why?
Radiation Chimera
1
1999
4
0.010
Why?
beta 2-Microglobulin
1
1999
39
0.010
Why?
Protein Engineering
1
1999
18
0.010
Why?
Plants, Toxic
1
1998
10
0.010
Why?
Enzyme Stability
1
1998
20
0.010
Why?
Plants, Genetically Modified
1
1998
18
0.010
Why?
Stem Cells
1
1999
166
0.010
Why?
Hot Temperature
1
1998
198
0.010
Why?
Signal Transduction
1
2003
1624
0.010
Why?
Mice, Knockout
1
1999
844
0.010
Why?
Mice, Inbred C57BL
1
1999
1808
0.010
Why?
Muscle, Skeletal
1
1999
784
0.010
Why?
Karbassi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description